Recruiting PHASE2 INTERVENTIONAL 1-arm NCT06660407

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Grid Radiotherapy for Advanced Non-Small Cell Lung Cancer at the Time of Progression on Immune Checkpoint Inhibition

Sponsor: Mayo Clinic

Conditions Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Interventions Biospecimen Collection Computed Tomography Immunotherapy Palliative Radiation Therapy Spatially-fractionated Radiation Therapy

Updated 3 times since 2024 Last updated: Apr 2, 2025 Started: Nov 14, 2024 Primary completion: Jan 10, 2027 Completion: Jan 10, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06660407, this PHASE2 trial focuses on Lung Non-Small Cell Carcinoma and Stage IV Lung Cancer AJCC v8 and remains actively recruiting participants. Sponsored by Mayo Clinic, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

May 2025 — Present [monthly]

Recruiting PHASE2
Dec 2024 — May 2025 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States